Abstract:Recent work has revealed an essential involvement of soluble CD40L (sCD40L) in inflammation and vascular disease. Activated platelets are the major source of sCD40L, which has been implicated in platelet and leukocyte activation, although its exact functional impact on leukocyte-platelet interactions and the underlying mechanisms remain undefined. We aimed to determine the impact and the mechanisms of sCD40L on neutrophils. We studied neutrophil interactions with activated, surface-adherent platelets as a model for leukocyte recruitment to the sites of injury. Our data show that CD40L contributes to neutrophil firm adhesion to and transmigration across activated surface-adherent platelets, possibly through two potential mechanisms. One involves the direct interaction of ligand-receptor (CD40L-CD40), i.e., platelet surface CD40L interaction with neutrophil CD40; another involves an indirect mechanism, i.e. soluble CD40L stimulates activation of the leukocyte-specific β2 integrin Mac-1 in neutrophils and thereby further promotes neutrophil adhesion and migration. Activation of the integrin Mac-1 is known to be critical for mediating neutrophil adhesion and migration. sCD40L activated Mac-1 in neutrophils and enhanced neutrophil-platelet interactions in wild-type neutrophils, but failed to elicit such responses in CD40-deficient neutrophils. Furthermore, our data show that the protein kinase C zeta (PKCζ) is critically required for sCD40L-induced Mac-1 activation and neutrophil adhesive function. sCD40L strongly stimulated the focal clustering of Mac-1 (CD11b) and the colocalization of Mac-1 with PKCζ in wild-type neutrophils, but had minimal effect in CD40-deficient neutrophils. Blocking PKCζ completely inhibited sCD40L-induced neutrophil firm adhesion. Moreover, sCD40L strongly stimulates neutrophil oxidative burst via CD40-dependent activation of PI3K/NF-KB, but independent of Mac-1 and PKCζ. These findings may contribute to a better understanding of the underlying mechanisms by which sCD40L/CD40 pathway contributes to inflammation and vascular diseases.

CD300e: Emerging role and mechanism as an immune-activating receptor

Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the Β2 Integrin Mac-1 and Protein Kinase C Zeda (pkcζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst

Slowly getting a clue on CD95 ligand biology.

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

CD300 molecule regulation of human dendritic cell functions

The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions

CD300a and CD300f molecules regulate the function of leukocytes

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy

CD300e as a Driver of Immunosuppressive Tumor Microenvironment in Colorectal Cancer

The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils

CD300b regulates intestinal inflammation and promotes repair in colitis

CD300f immune receptor is a microglial tissue damage sensor and regulates efferocytosis after brain damage

CD14: Biology and role in the pathogenesis of disease

The multifunctional nature of CD103 (αEβ7 integrin) signaling in tissue-resident lymphocytes

CD300 receptor family in viral infections

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

The biological function and significance of CD74 in immune diseases

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases

AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease

The immunoreceptor CD300a controls the intensity of inflammation and dysfunction in a model of Ag-induced arthritis in mice